MoneyWorks4Me

FDC - Quaterly Results

09 Feb 2023 Evaluate
The Revenue for the quarter ended  December 2022 of Rs. 4066.06 millions grew by 19.20 % from Rs. 3411.11 millions.The Company has registered profit of Rs. 394.31  millions for the quarter ended December 2022, a growth of 24.80%  over Rs. 315.95 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 652.83 millions from the corresponding previous quarter of 565.76 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 4066.06 3411.11 19.20 13458.35 11823.58 13.83 15189.65 13254.49 14.60
Other Income 187.63 131.22 42.99 667.93 671.32 -0.50 787.34 971.46 -18.95
PBIDT 652.83 565.76 15.39 2444.61 2967.71 -17.63 3255.80 4214.76 -22.75
Interest 11.84 8.44 40.28 28.91 23.61 22.45 30.48 34.02 -10.41
PBDT 640.99 557.32 15.01 2415.70 2944.10 -17.95 3225.32 4180.74 -22.85
Depreciation 98.12 89.87 9.18 290.67 279.18 4.12 370.81 376.23 -1.44
PBT 542.87 467.45 16.13 2125.03 2664.92 -20.26 2854.51 3804.51 -24.97
TAX 148.56 151.50 -1.94 487.77 612.37 -20.35 658.15 859.61 -23.44
Deferred Tax 32.56 6.50 400.92 -54.23 -33.63 61.25 -21.85 14.45 -251.21
PAT 394.31 315.95 24.80 1637.26 2052.55 -20.23 2196.36 2944.90 -25.42
Equity 165.91 168.81 -1.72 165.91 168.81 -1.72 168.81 168.81 0.00
PBIDTM(%) 16.06 16.59 -3.20 18.16 25.10 -27.63 21.43 31.80 -32.59
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..